Day: February 15, 2024

WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it has scheduled its fourth quarter and year end 2023 financial results and corporate update for Thursday, February 29, 2024. The schedule for the press release and conference call/webcast are as follows:• Q4 and Year End 2023 Press Release: Thursday, February 29, 2024 at 7:30 a.m. ET• Q4 and Year End 2023 Conference Call/Webcast: Thursday, February 29, 2024 at 8:45 a.m. ETTo dial-in for the conference call by phone, please register using the following link: Registration Link. A live webcast of the conference call can be accessed through...

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc. (the “Company” or “Evome”) announces the appointment of two senior healthcare executives to its Board of Directors.‎ Mr. Wayne Anderson, former President and CEO of Ferring Pharmaceuticals USA, has joined as a non-executive ‎member of the Board of Directors.‎ Mr. Bill Garbarini, a former Ferring Pharmaceuticals USA executive and current COO of Conceivable Life Sciences, a venture backed in-vitro fertilization company, will also join as a non-executive member of the Board of Directors. In addition, Kenneth Kashkin, MD, has been appointed Chairman of the Board of Directors. Dr. Kashkin is Board Certified in Internal Medicine, Neurology & Psychiatry with training at, and serving on, the faculties of the University of California, Los Angeles (UCLA) and...

LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today reported financial results for the fiscal second quarter ended December 31, 2023. The Company plans to issue another announcement following today’s report of financial results regarding the date and time of its conference call and webcast to discuss second quarter financial results and other key events. The Company made significant progress during the quarter in revenue generation, reimbursement coverage, the publication of real-world evidence and operating cost management, setting the stage for potential future growth. Highlights include:During the three months ended December 31,...

CLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) — Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2023 before the market opens on Tuesday, February 27, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results. To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company’s website...

EATONTOWN, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to announce their partnership with Panzura, an award-winning, hybrid, multi-cloud, end-to-end data management platform, with the signing of a worldwide contract. Through this partnership, Panzura will utilize Climb Channel Solutions’ network of partners to build relationships and accelerate the company’s growth as a channel-first organization. Climb will be working with and onboarding 99% of Panzura’s current DVARs to grow their business. Current resellers of Panzura will be able to take advantage of Climb’s fast, agile, and flexible business model, as well as a full stack of solutions with over 100 vetted vendors. Climb’s...